PAPER
Enantioselective Synthesis of 2,3-Dihydro-1,2,4-oxadiazoles
3215
7.10 (m, 2 H, HPh), 7.22–7.58 (m, 11 H, HPh), 8.05 (d, J = 7.5 Hz, 2
HRMS (ESI): m/z [M + H]+ calcd for C23H23N2O: 343.1732; found:
H, HPh).
343.1734.
13C NMR (100.62 MHz, CDCl3): d = 21.7, 67.2, 89.3, 125.6, 126.0,
126.4, 128.0, 128.1, 128.3, 128.6, 126.8, 129.1, 132.1, 139.9, 140.9,
161.2.
HRMS (ESI): m/z [M + H]+ calcd for C22H21N2O: 329.1576; found:
329.1578.
(+)-(1¢R,3S)-9
Yellow oil; [a]D24.0 +27.0 (c 0.02, CHCl3).
IR (CHCl3): 3020, 2928, 2857, 1657, 1452, 1375, 1090 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.52 (d, J = 6.7 Hz, 3 H, CH3CH),
2.33 (s, 3 H, PhCH3), 4.20 (q, J = 6.7 Hz, 1 H, CH3CHPh), 6.09 (s,
1 H, NCHN), 7.16 (d, J = 8.0 Hz, 2 H, HPh), 7.28–7.49 (m, 10 H,
HPh), 7.77 (d, J = 8.0 Hz, 2 H, HPh).
(–)-(1¢S,3R)-7
Yellow oil; [a]D24.0 –60.0 (c 0.02, CHCl3).
IR (CHCl3): 3030, 2988, 2927, 1655, 1495, 1452, 1322, 1220 cm–1.
13C NMR (100.62 MHz, CDCl3): d = 19.4, 21.2, 66.2, 88.9, 125.5,
126.6, 127.6, 127.9, 128.4, 128.5, 129.2, 130.9, 131.8, 137.7, 137.9,
141.3, 160.9.
1H NMR (400 MHz, CDCl3): d = 1.54 (d, J = 6.6 Hz, 3 H, CH3),
4.22 (q, J = 6.6 Hz, 1 H, CH3CHPh), 6.13 (s, 1 H, NCHN), 7.22–
7.52 (m, 13 H, HPh), 7.78(d, J = 7.0 Hz, 2 H, HPh).
HRMS (ESI): m/z [M + H]+ calcd for C23H23N2O: 343.1732; found:
343.1731.
13C NMR (100.62 MHz, CDCl3): d = 19.3, 66.2, 88.9, 125.5, 126.7,
127.1, 127.6, 127.9, 128.2, 128.4, 128.5, 129.1, 131.8, 140.6, 141.2,
161.0.
HRMS (ESI): m/z [M + H]+ calcd for C22H21N2O: 329.1576; found:
329.1577.
5-(Benzothiazol-2-yl)-3-phenyl-2-(1-phenylethyl)-2,3-dihydro-
1,2,4-oxadiazole (10)
A soln of benzothiazole-2-carbonitrile (BTCN, 1.5 mmol) and ox-
aziridine 4 (1.0 mmol) in toluene (10 mL) was refluxed under mag-
netic stirring (TLC monitoring). When the reaction was complete,
the soln was cooled to r.t. and the solvent was evaporated under re-
duced pressure giving a yellow crude material. The products were
isolated by flash chromatography (silica gel, PE–Et2O, 9:1) and
identified by spectroscopic analysis; GC-MS: both compounds
were unstable on the chromatography column.
3-(4-Chlorophenyl)-5-phenyl-2-(1-phenylethyl)-2,3-dihydro-
1,2,4-oxadiazole (8)
(+)-(1¢S,3S)-8
Yellow solid; mp 61.5–63.0 °C; [a]D24.0 +77.5 (c 0.02, CHCl3).
IR (CHCl3): 3030, 2987, 2927, 2855, 1654, 1492, 1452, 1322, 1090
cm–1.
(–)-(1¢R,3R)-10
1H NMR (400 MHz, CDCl3): d = 1.66 (d, J = 6.3 Hz, 3 H, CH3),
4.10 (q, J = 6.3 Hz, 1 H, CH3CHPh), 5.85 (s, 1 H, NCHN), 7.02 (d,
J = 8.3 Hz, 2 H, HPh), 7.19 (d, J = 8.3 Hz, 2 H, HPh), 7.31–7.36 (m,
5 H, HPh), 7.48 (t, J = 7.7 Hz, 2 H, HPh), 7.55 (d, J = 7.3 Hz, 1 H,
HPh), 8.02 (d, J = 8.3 Hz, 2 H, HPh).
13C NMR (100.62 MHz, CDCl3): d = 21.7, 67.3, 88.8, 125.4, 127.9,
128.3, 128.4, 128.6, 128.8, 128.9, 132.2, 133.8, 138.6, 140.7, 161.4.
Yellow solid; mp 90–92 °C; [a]D24.0 –34.9 (c 0.02, CHCl3).
IR (CHCl3): 3030, 3007, 2927, 2854, 1655, 1495, 1454, 1376, 1310,
1080 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.73 (d, J = 6.4 Hz, 3 H, CH3CH),
4.23 (q, J = 6.4 Hz, 1 H, CH3CHPh), 6.00 (s, 1 H, NCHN), 7.18–
7.40 (m, 10 H, HPh), 7.50–7.60 (m, 2 H, HBTz), 7.97 (d, J = 7.8 Hz,
1 H, HBTz), 8.24 (d, J = 8.2 Hz, 1 H, HBTz).
13C NMR (100.62 MHz, CDCl3): d = 21.7, 67.6, 89.5, 121.8, 124.9,
125.0, 126.6, 127.0, 127.2, 127.9, 128.3, 128.8, 131.3, 136.0, 137.1,
140.3, 153.4, 156.4.
HRMS (ESI): m/z [M + H]+ calcd for C22H20ClN2O: 363.1186;
found: 363.1187.
(–)-(1¢S,3R)-8
Yellow oil; [a]D24.0 –72.1 (c 0.02, CHCl3).
HRMS (ESI): m/z [M + H]+ calcd for C23H20N3OS: 386.1249;
found: 386.1751.
IR (CHCl3): 3030, 2926, 2855, 1656, 1490, 1457, 1375, 1091 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.53 (d, J = 6.6 Hz, 3 H, CH3),
4.23 (q, J = 6.6 Hz, 1 H, CH3CHPh), 6.08 (s, 1 H, NCHN), 7.30–
7.42 (m, 10 H, HPh), 7.48 (t, J = 7.4 Hz, 2 H, HPh), 7.77 (d, J = 8.4
Hz, 2 H, HPh).
13C NMR (100.62 MHz, CDCl3): d = 22.7, 66.1, 88.1, 125.2, 127.8,
128.1, 128.2, 128.3, 128.4, 128.5, 132.0, 134.0, 139.2, 140.8, 161.3.
(+)-(1¢R,3S)-10
Colorless crystal; mp 78–80 °C; [a]D24.0 +38.7 (c 0.02, CHCl3).
IR (CHCl3): 3030, 3008, 2927, 2856, 1661, 1496, 1455, 1377, 1311,
1080 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.63 (d, J = 6.7 Hz, 3 H, CH3CH),
4.33 (q, J = 6.7 Hz, 1 H, CH3CHPh), 6.16 (s, 1 H, NCHN), 7.27–
7.63 (m, 12 H, HPh, HBTz), 7.91 (d, J = 7.8 Hz, 1 H, HBTz), 8.19 (d,
J = 8.2 Hz, 1 H, HBTz).
HRMS (ESI): m/z [M + H]+ calcd for C22H20ClN2O: 363.1186;
found: 363.1185.
13C NMR (100.62 MHz, CDCl3): d = 18.5, 66.5, 88.8, 121.8, 124.9,
125.3, 126.8, 127.0, 127.7, 128.0, 128.5, 129.1, 131.8, 135.9, 139.3,
139.5, 153.1, 156.2.
HRMS (ESI): m/z [M + H]+ calcd for C23H20N3OS: 386.1249;
found: 386.1750.
5-Phenyl-2-(1-phenylethyl)-3-(4-tolyl)-2,3-dihydro-1,2,4-oxadi-
azole (9)
(–)-(1¢R,3R)-9
Yellow oil; [a]D24.0 –38.5 (c 0.02, CHCl3).
IR (CHCl3): 3020, 2927, 2858, 1657, 1453, 1375, 1090 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.65 (d, J = 6.4 Hz, 3 H, CH3CH),
2.27 (s, 3 H, PhCH3), 4.09 (q, J = 6.4 Hz, 1 H, CH3CHPh), 5.86 (s,
1 H, NCHN), 6.97 (d, J = 8.1 Hz, 2 H, HPh), 7.04 (d, J = 8.1 Hz, 2
H, HPh), 7.28–7.38 (m, 5 H, HPh), 7.47 (t, J = 7.2 Hz, 2 H, HPh), 7.54
(d, J = 7.3 Hz, 1 H, HPh), 8.03 (d, J = 8.3 Hz, 2 H, HPh).
13C NMR (CDCl3): d = 21.1, 22.8, 67.2, 89.3, 126.3, 128.1, 128.4,
128.6, 128.7, 128.8, 129.0, 129.1, 132.0, 137.1, 137.7, 141.1, 161.1.
Acknowledgment
This work was carried out under the framework of the University of
Salento and the C.I.N.M.P.I.S. (Consorzio Interuniversitario Nazio-
nale Metodologie e Processi Innovativi di Sintesi) for the financial
support.
Synthesis 2010, No. 18, 3211–3216 © Thieme Stuttgart · New York